C2 Capital Partners

What C2 Capital Partners does

C2 Capital Partners – SGOIC, S.A. is an independent Portuguese private equity fund management company founded in 2009 and headquartered in Lisbon. Registered and supervised by the CMVM (Portuguese Securities Market Commission), the firm operates two main business lines with dedicated autonomous management teams: Growth Capital (Capital de Expansão) and Alternative Investments (Investimentos Alternativos). It manages 17 funds, including C2 Growth I (2011) through R&D Growth XII, Legacy Buyout, Atlantic Open-Ended Fund, Aster C2 Prime Fund I, MedCapital, C2 FIAE Real Estate & Tourism, and M4 Ventures PT I, with several vehicles structured to be eligible for the Portuguese Golden Visa program.

The firm invests across healthcare, hospitality, manufacturing, sustainability, lighting technology, real estate, and tourism, with a disclosed portfolio of 60+ companies. Notable transactions include the December 2022 acquisition of Clarel (a 1,015-store perfume retail chain) from DIA for approximately €60 million, and a June 2026 €15 million financing to IMG Group for the Everbio Innovation Hub, a recycled and biobased polymer materials platform. C2 Capital Partners is an affiliate of Gaw Capital Partners, a Hong Kong-based private equity firm with $36 billion in AUM and offices across 15+ global locations, providing cross-border deal flow and capital backing. The team comprises 35+ professionals covering investing, compliance, legal, valuation, risk, finance, and asset management functions.

Revenue is generated through two standard PE fund-manager streams: recurring management fees on committed/invested capital across its 17 funds, and performance-based carried interest tied to portfolio exits. The firm became a signatory to the UN Principles for Responsible Investment (PRI) in 2020 and is a member of IPCG and APCRI, formalizing ESG and industry-association positioning within the Portuguese capital de risco ecosystem.

Name

C2 Capital Partners

Legal name

C2 Capital Partners – SGOIC, S.A.

Website

https://c2capital.pt

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

C2 Capital Partners is an independent Portuguese private equity firm founded in 2009 and registered with the CMVM. It manages 17 funds across Growth Capital and Alternative Investments, investing in 60+ Iberian portfolio companies. It is an affiliate of Gaw Capital Partners.

Ownership category

akta.pro rank

Product category

Private Equity Management

NAICS

Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investors, Nec (6799)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Private equity management
• Venture capital funding
• Growth capital investment
• Alternative investment funds
• Portfolio company support

Headquarters

HQ city

Lisboa

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Fund Management Fees: C2 Capital Partners generates revenue through management fees charged on assets under management across its multiple funds (Growth I through XII, Legacy Buyout, Atlantic Open-Ended, Aster C2 Prime Fund I, and others). These are typically structured as a percentage of committed capital or invested assets.
2. Carried Interest: Performance-based carried interest from successful portfolio company exits and investments, typically a percentage of profits above a hurdle rate returned to investors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

C2 Capital Partners is a Portuguese private equity fund management company that raises and manages investment funds across two main business areas: Growth Capital (Capital de Expansão) and Alternative Investments. The firm invests in portfolio companies across multiple industries (healthcare, hospitality, sustainability, real estate, technology) in Portugal and provides capital, operational support, strategic guidance, and exit planning. Its funds include Growth series (I-XII), R&D-focused funds, sector-specific vehicles (MedCapital, C2 FIAE), venture funds (Ventures PT I), buyout funds (Legacy Buyout, M4), and Golden Visa-eligible open-ended funds (Atlantic Open-Ended Fund, Aster C2 Prime Fund I).

Product overview

C2 Capital Partners is an independent private equity fund management firm offering two main business areas: Capital de Expansão (Growth Capital) and Investimentos Alternativos (Alternative Investments), each with dedicated autonomous management teams. The firm manages a diversified portfolio of funds including Growth funds (C2 Growth I), R&D-focused funds (R&D Growth III through XII), sector-specific funds (MedCapital for healthcare, C2 FIAE for real estate & tourism), venture funds (Ventures PT I), and buyout funds (Legacy Buyout, M4). The firm also manages open-ended funds (Atlantic Open-Ended Fund, Aster C2 Prime Fund I) and operates as an affiliate of Gaw Capital Partners, providing access to international networks and broader investment opportunities across various industries and geographies in Portugal.

Differentiator

Problem solved

Functional benefit

Products and services

• Capital de Expansão (Growth Capital) Growth Capital investment strategy providing expansion capital, operational support, strategic guidance, and exit planning to companies in Portugal across various industries and geographies. Operated through a dedicated autonomous management team.
• Investimentos Alternativos (Alternative Investments) Alternative Investments strategy providing specialized alternative investment opportunities including R&D-focused funds, real estate and tourism, healthcare, and venture investments. Operated through a dedicated autonomous management team.
• C2 Growth I Fund First growth fund of C2 Capital Partners, registered with CMVM (number 1270), launched in 2011. Targets growth-stage companies in Portugal.
• R&D Growth Funds III through XII Series of R&D-focused growth funds (III, IV, V, VI, VII, VIII, IX, XI, XII) launched between 2017 and 2025, registered with CMVM, targeting innovation and research & development investments.
• C2 Legacy Buyout Fund Buyout fund launched in 2024, registered with CMVM (number 2037), eligible for Golden Visa, focused on buyout opportunities in the Portuguese market. Currently in fundraising.
• Atlantic Open-Ended Fund – FIAM Open-ended fund eligible for Golden Visa, launched in 2025, registered with CMVM (number 2300).
• Aster C2 Prime Fund I – FIAM Open-ended fund launched in 2025, registered with CMVM (number 2318).
• MedCapital Fund Healthcare-focused fund registered with CMVM (number 1609), launched in 2020.
• C2 FIAE Real Estate & Tourism Fund Real estate and tourism focused fund registered with CMVM (number 1613), launched in 2020.
• Ventures PT I Fund Venture fund launched in 2021, registered with CMVM (number 1767).
• M4 Fund Fund launched in 2021, providing additional investment vehicle capacity alongside other C2 funds.

Quantifiable outcome

• 17 funds under management including Growth I-XII, Legacy Buyout, and specialized vehicles
• +1 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/c2-capital-partners

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about C2 Capital Partners